Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK13 | O15264 | 2/20 | 0.67 |
| ▸ | MAPK12 | P53778 | 2/20 | 0.67 |
| ▸ | MAPK11 | Q15759 | 2/20 | 0.67 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.66 |
| ▸ | RAB9A | P51151 | 5/20 | 0.62 |
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 4/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL52136 | 0.91 | ALDH1A1 (0.52) | MAPK13MAPK12MAPK11MAPK14ALDH1A1 | |
| Benzophenone SCHEMBL329684 | 0.84 | ALDH1A1 (0.78) | MAPK13MAPK12MAPK11MAPK14ALDH1A1 | |
| Benzophenone SCHEMBL28325902 | 0.84 | ALDH1A1 (0.78) | MAPK13MAPK12MAPK11MAPK14ALDH1A1 | |
| Benzophenone SCHEMBL28328302 | 0.84 | ALDH1A1 (0.78) | MAPK13MAPK12MAPK11MAPK14ALDH1A1 | |
| SCHEMBL25652847 | 0.83 | ALDH1A1 (0.70) | ALDH1A1RAB9ANPC1SMN1; SMN2SRD5A2 | |
| SCHEMBL23268506 | 0.82 | TSHR (0.59) | MAPK13MAPK12MAPK11MAPK14ALDH1A1 | |
| SCHEMBL14283579 | 0.82 | TSHR (0.59) | MAPK13MAPK12MAPK11MAPK14ALDH1A1 | |
| SCHEMBL29196087 | 0.82 | MAPK13 (0.95) | MAPK13MAPK12MAPK11MAPK14ALDH1A1 | |
| SCHEMBL9645083 | 0.82 | L3MBTL1 (0.63) | MAPK13MAPK12MAPK11MAPK14ALDH1A1 | |
| SCHEMBL22212597 | 0.81 | ACHE (0.54) | RAB9ANPC1MEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0123493-A1 | Photochemical conversion and storage of light energy by photoisomerization of compounds such as norbornadiene and its derivatives | THE STANDARD OIL COMPANY (US) | 1984-10-31 | — | — | EP | claimed |
| US-12319661-B2 | Polycyclic compound | EUTEC NEW MATERIALS TECHNOLOGY (SUZHOU) CO., LTD. (CN) | 2025-06-03 | — | — | US | disclosed |
| CN-115819359-B | Blue light preventing compound, preparation method and composition thereof | 江苏裕事达新材料科技有限责任公司 | 2025-04-18 | — | — | CN | disclosed |
| CN-115745970-B | Polycyclic compound, preparation method and membrane | 江苏裕事达新材料科技有限责任公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-118359321-A | Application of deinococcus in degradation of malachite green wastewater | 扬州工业职业技术学院 | 2024-07-19 | — | — | CN | disclosed |
| US-20240024266-A1 | Therapeutic Agent or Prophylactic Agent for COVID-19 | HIROSHIMA UNIVERSITY (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20240025873-A1 | METHOD FOR PRODUCING KETONE DERIVATIVE | TOKUYAMA CORPORATION (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20240025873-A1 | METHOD FOR PRODUCING KETONE DERIVATIVE | TOKUYAMA CORPORATION (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20240024266-A1 | Therapeutic Agent or Prophylactic Agent for COVID-19 | HIROSHIMA UNIVERSITY (JP) | 2024-01-25 | — | — | US | disclosed |
| US-11845824-B2 | Same novel polymer and organic light emitting device comprising the same | LG CHEM, LTD. | 2023-12-19 | — | — | US | disclosed |
| US-20100273842-A1 | AMINE DERIVATIVES HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY AND THE USES THEREOF | SHIONOGI & CO., LTD. (JP) | 2010-10-28 | — | — | US | disclosed |
| US-20100267945-A1 | AMINE DERIVATIVE HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY | SHIONOGI & CO., LTD. (JP) | 2010-10-21 | — | — | US | disclosed |
| WO-2008067928-A1 | UV ABSORBING COMPOSITIONS CONTAINING A PYRROLYLTRIAZINE | ISDIN S.A. (ES) | 2008-06-12 | — | — | WO | disclosed |
| US-5792589-A | ORGANIC BINDER; OPTICALLY CROSSLINKABLE COMPOUND; RADICAL-GENERATING AGENT: 2,4,5-TRIARYL IMIDAZOLE DIMER, AMINO-GROUP CONTAINING BENZOPHENONE PHOTOSENSITIZER, A THIOL COMPOUND | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1998-08-11 | — | — | US | disclosed |
| US-4163810-A | Ultraviolet curable powder paints | SCM CORPORATION (US) | 1979-08-07 | — | — | US | disclosed |
| US-4129488-A | Ultraviolet curable epoxy-polyester powder paints | SCM CORPORATION (US) | 1978-12-12 | — | — | US | disclosed |
| US-4105518-A | POLYMER CONTAINING ACRYLYL, ACRYLAMIDE OR ALLYL UNSATURATED GROUPS, REACTED WITH SECONDARY AMINE AND NEUTRALIZED, SENSITIZER | SCM CORPORATION (US) | 1978-08-08 | — | — | US | disclosed |
| US-4052280-A | PHOTOSENTIZER IN BACKBONE OF POLYMER | SCM CORPORATION (US) | 1977-10-04 | — | — | US | disclosed |
| US-4040925-A | PAINTS; CHEMICALLY BONDED ULTRAVIOLET SENSITIZER | SCM CORPORATION (US) | 1977-08-09 | — | — | US | disclosed |
| US-4039414-A | ACRYLYL, ACRYLAMIDE, OR ALLYL POLYMERS, BENZALDEHYDE SENSITIZER | SCM CORPORATION (US) | 1977-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100273842-A1 | AMINE DERIVATIVES HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY AND THE USES THEREOF | NPY5R, NPY1R, NPY2R | MAPK13 977/4885MAPK12 1267/4885MAPK11 1048/4885 |
| US-20100267945-A1 | AMINE DERIVATIVE HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY | NPY5R, NPY1R, NPY2R | MAPK13 1651/4885MAPK12 2240/4885MAPK11 1558/4885 |
| US-12319661-B2 | Polycyclic compound | CUTA, CDH1, DSG1 | MAPK13 2527/4885MAPK12 3899/4885MAPK11 2393/4885 |
| US-20240025873-A1 | METHOD FOR PRODUCING KETONE DERIVATIVE | HSD17B7, BCKDK, KARS1 | MAPK13 2055/4885MAPK12 1702/4885MAPK11 1502/4885 |
| US-20240024266-A1 | Therapeutic Agent or Prophylactic Agent for COVID-19 | PIN1, ACE2, ACE | MAPK13 304/4885MAPK12 167/4885MAPK11 352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.